Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GENOMIC EXPRESSION ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   3.6% 6.6% 9.1% 9.2% 10.0% 11.4% 16.4% 13.3%   Credit score (0-100)   55 37 28 27 23 20 10 17   Credit rating   BBB BBB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   879 525 -418 -249 -11.0 -89.0 0.0 0.0   EBITDA   749 142 -552 -557 -11.1 -275 0.0 0.0   EBIT   607 -16.6 -710 -715 -169 -433 0.0 0.0   Pre-tax profit (PTP)   597.0 -946.9 189.4 -637.9 -176.3 -434.6 0.0 0.0   Net earnings   597.0 -946.9 189.4 -637.9 -176.3 -434.6 0.0 0.0   Pre-tax profit without non-rec. items   597 -947 189 -638 -176 -435 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   947 0.6 190 -448 -624 -1,059 -1,461 -1,461   Interest-bearing liabilities   230 72.8 0.0 1,414 1,408 1,285 1,869 1,869   Balance sheet total (assets)   13,701 8,935 2,765 1,154 972 414 408 408   Net Debt   -12,180 -7,225 -1,482 1,394 1,400 1,285 1,869 1,869     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   879 525 -418 -249 -11.0 -89.0 0.0 0.0   Gross profit growth   418.1% -40.3% 0.0% 40.5% 95.6% -709.9% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   13,701 8,935 2,765 1,154 972 414 408 408   Balance sheet change%   2,021.5% -34.8% -69.0% -58.3% -15.8% -57.4% -1.5% 0.0%   Added value   606.6 -16.6 -710.1 -714.7 -169.3 -432.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   535 -316 -216 -316 -316 -316 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 -4.0 -5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   69.0% -3.2% 170.0% 287.4% 1,540.2% 486.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.5% 0.1% 4.2% -27.4% -10.6% -28.2% 0.0% 0.0%   ROI %   68.8% 1.5% 187.4% -74.5% -12.0% -32.2% 0.0% 0.0%   ROE %   92.0% -199.7% 198.7% -94.9% -16.6% -62.7% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   6.9% 0.0% 6.9% -28.0% -39.1% -71.9% -78.2% -78.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,625.5% -5,103.8% 268.5% -250.4% -12,600.4% -467.5% 0.0% 0.0%   Gearing %   24.3% 11,625.7% 0.0% -315.7% -225.6% -121.3% -127.9% -127.9%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.2% 631.4% 157.7% 5.7% 0.5% 0.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.0 0.9 0.7 0.3 0.3 0.0 0.0 0.0   Current Ratio   1.0 0.9 0.7 0.3 0.3 0.0 0.0 0.0   Cash and cash equivalent   12,410.1 7,298.2 1,482.2 20.5 7.9 0.1 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -151.5 -940.2 -692.5 -1,172.2 -1,190.4 -1,466.9 -934.6 -934.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   607 -17 -710 -715 -169 -433 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   749 142 -552 -557 -11 -275 0 0   EBIT / employee   607 -17 -710 -715 -169 -433 0 0   Net earnings / employee   597 -947 189 -638 -176 -435 0 0